{"@context":{"@vocab":"https://schema.org/","scidex":"https://scidex.ai/vocab/"},"@type":"Dataset","name":"Bibliography — ubiquitylation-dependent turnover is the actionable driver in: How do ALS-linked UBQLN2 mutations affect its ubiquitylation-dependent stability and local","about":{"@type":"CreativeWork","identifier":"h-gap-92152803-m1"},"generatedAt":"2026-06-11T21:25:54Z","@graph":[{"@type":"ScholarlyArticle","identifier":"39195279","name":"Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies.","author":"Nong T, Mehra S, Taylor J","isPartOf":{"@type":"Periodical","name":"Cells"},"datePublished":"2024","url":"https://pubmed.ncbi.nlm.nih.gov/39195279/"},{"@type":"ScholarlyArticle","identifier":"37073562","name":"Targeted therapy for lung cancer: Beyond EGFR and ALK.","author":"Herrera-Juárez M, Serrano-Gómez C, Bote-de-Cabo H","isPartOf":{"@type":"Periodical","name":"Cancer"},"datePublished":"2023","url":"https://pubmed.ncbi.nlm.nih.gov/37073562/"},{"@type":"ScholarlyArticle","identifier":"34273246","name":"UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.","author":"[\"Lin Brian C\", \"Higgins Nicole R\", \"Phung Trong H\", \"Monteiro Mervyn J\"]","isPartOf":{"@type":"Periodical","name":"The FEBS journal"},"datePublished":"2022","url":"https://pubmed.ncbi.nlm.nih.gov/34273246/"},{"@type":"ScholarlyArticle","identifier":"34273246","name":"UBQLN proteins in health and disease with a focus on UBQLN2 in ALS/FTD.","author":"Lin BC, Higgins NR, Phung TH","isPartOf":{"@type":"Periodical","name":"FEBS J"},"datePublished":"2022","url":"https://pubmed.ncbi.nlm.nih.gov/34273246/"},{"@type":"ScholarlyArticle","identifier":"34985916","name":"Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.","author":"Tan AC, Tan DSW","isPartOf":{"@type":"Periodical","name":"J Clin Oncol"},"datePublished":"2022","url":"https://pubmed.ncbi.nlm.nih.gov/34985916/"},{"@type":"ScholarlyArticle","identifier":"35948633","name":"Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.","author":"Zingg D, Bhin J, Yemelyanenko J","isPartOf":{"@type":"Periodical","name":"Nature"},"datePublished":"2022","url":"https://pubmed.ncbi.nlm.nih.gov/35948633/"},{"@type":"ScholarlyArticle","identifier":"33031745","name":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.","author":"Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J, De Nardo D","isPartOf":{"@type":"Periodical","name":"Cell"},"datePublished":"2020","url":"https://pubmed.ncbi.nlm.nih.gov/33031745"},{"@type":"ScholarlyArticle","identifier":"33031745","name":"TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS.","author":"Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J, De Nardo D","isPartOf":{"@type":"Periodical","name":"Cell"},"datePublished":"2020","url":"https://pubmed.ncbi.nlm.nih.gov/33031745/"},{"@type":"ScholarlyArticle","identifier":"30643298","name":"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.","author":"Melamed Ze'ev; López-Erauskin Jone; Baughn Michael W; Zhang Ouyang; Drenner Kevin; Sun Ying; Freyermuth Fernande; McMahon Moira A; Beccari Melinda S; Artates Jon W; Ohkubo Takuya; Rodriguez Maria; Lin Nianwei; Wu Dongmei; Bennett C Frank; Rigo Frank; Da Cruz Sandrine; Ravits John; Lagier-Tourenne Clotilde; Cleveland Don W","isPartOf":{"@type":"Periodical","name":"Nature neuroscience"},"datePublished":"2019","url":"https://pubmed.ncbi.nlm.nih.gov/30643298/"},{"@type":"ScholarlyArticle","identifier":"30643298","name":"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.","author":"Melamed Z, López-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, Freyermuth F, McMahon MA, Beccari MS, Artates JW, Ohkubo T, Rodriguez M, Lin N, Wu D, Bennett CF, Rigo F, Da Cruz S, Ravits J, Lagier-Tourenne C, Cleveland DW","isPartOf":{"@type":"Periodical","name":"Nature neuroscience"},"datePublished":"2019","url":"https://pubmed.ncbi.nlm.nih.gov/30643298/"},{"@type":"ScholarlyArticle","identifier":"30948552","name":"Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.","author":"Maniatis S, Äijö T, Vickovic S, Braine C, Kang K, Mollbrink A, Fagegaltier D, Andrusivová Ž, Saarenpää S, Saiz-Castro G, Cuevas M, Watters A, Lundeberg J, Bonneau R, Phatnani H","isPartOf":{"@type":"Periodical","name":"Science (New York, N.Y.)"},"datePublished":"2019","url":"https://pubmed.ncbi.nlm.nih.gov/30948552/"},{"@type":"ScholarlyArticle","identifier":"30948552","name":"Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis.","author":"Maniatis S, Äijö T, Vickovic S, Braine C, Kang K, Mollbrink A, Fagegaltier D, Andrusivová Ž, Saarenpää S, Saiz-Castro G, Cuevas M, Watters A, Lundeberg J, Bonneau R, Phatnani H","isPartOf":{"@type":"Periodical","name":"Science (New York, N.Y.)"},"datePublished":"2019","url":"https://pubmed.ncbi.nlm.nih.gov/30948552/"},{"@type":"ScholarlyArticle","identifier":"26424568","name":"Human endogenous retrovirus-K contributes to motor neuron disease.","author":"Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A","isPartOf":{"@type":"Periodical","name":"Science translational medicine"},"datePublished":"2015","url":"https://pubmed.ncbi.nlm.nih.gov/26424568/"},{"@type":"ScholarlyArticle","identifier":"26424568","name":"Human endogenous retrovirus-K contributes to motor neuron disease.","author":"Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A","isPartOf":{"@type":"Periodical","name":"Science translational medicine"},"datePublished":"2015","url":"https://pubmed.ncbi.nlm.nih.gov/26424568/"},{"@type":"ScholarlyArticle","identifier":"12787319","name":"Neurotrophins and neurodegeneration.","author":"Dawbarn D, Allen SJ","isPartOf":{"@type":"Periodical","name":"Neuropathology and applied neurobiology"},"datePublished":"2003","url":"https://pubmed.ncbi.nlm.nih.gov/12787319/"},{"@type":"ScholarlyArticle","identifier":"12787319","name":"Neurotrophins and neurodegeneration.","author":"Dawbarn D, Allen SJ","isPartOf":{"@type":"Periodical","name":"Neuropathology and applied neurobiology"},"datePublished":"2003","url":"https://pubmed.ncbi.nlm.nih.gov/12787319/"}]}